HDB animal facility has received approval from an unnamed global pharmaceutical company for its in vivo research.

HD Biosciences announced today that its animal facility has received approval from an unnamed global pharmaceutical company for its in vivo research. HDB is commitment to complying with applicable international and low laws, regulations, and standard regarding humane animal care and use. Our in vivo pharmacologists are well trained and have extensive experience in drug discovery in several therapeutical areas.